Soma Pharmacy Blognews

Ipsen, Debiopharm Sign License Agreement
Debiopharm will develop and commercialise inhibitor of the CDC25 phosphatase enzyme

Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica
The agreement to last for five years

Karolinska Development Completes Successful Phase II Clinical Trial For Tafoxiparin
Tafoxiparin, a new drug substance for the prevention of protracted labor during childbirth

Hard To Treat Diseases Completes Clinical Trial For NUTRIPROTEIN
Cerebroprotein Hydrolysate, an injection, subject to approval will be launched in China

HGS Presents Results For Lupus Trial
Study evaluates Benlysta in serologically active patients with SLE

Array Reports Preliminary Results From Phase 2 Trial Of ARRY-162
In 12-week study, drug fails to meet the primary endpoint

Insects can be used to test the efficiency of new drugs
Insects, such as some moths and fruit flies, react to microbial infection in the same way as mammals and so can be used to test the efficiency of new drugs, thereby reducing the need for animal testing. Dr Kevin Kavanagh from the National University of [...]

Reversible cell-specific drug delivery with aptamer-functionalized liposomes
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug also must spare healthy cells, and ideally its effects will be reversible to cut short any potentially dangerous side effects. Investigators from the University of Illinois at Urbana-Champaign report that [...]

Regurin XL capsule for the treatment of OAB launched in UK
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side [...]

Identifying a specific molecular signature can help customize cancer treatment
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for [...]